Stay updated on Pembrolizumab CNS Metastases Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab CNS Metastases Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a pembrolizumab study of central nervous system metastases is available, with details on participation, study design, measures, and supporting documents.
    Difference
    68%
    Check dated 2026-11-09T23:41:51.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer now shows revision v3.8.0 instead of v3.7.2, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T23:30:43.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces updates about the agency’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-26T23:24:30.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label on the ClinicalTrials.gov 403 error page changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T23:28:46.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1; the page itself continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-13T05:49:48.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, making the study record inaccessible. This indicates an access issue rather than an update to the study content.
    Difference
    22%
    Check dated 2026-09-21T23:54:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab CNS Metastases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab CNS Metastases Clinical Trial page.